Genetic testing for Alpha 1 Antitrypsin Deficiency helps identify inherited changes that may affect the production or function of alpha 1 antitrypsin, a protein that protects the lungs and supports normal liver function. Testing can provide information about specific gene variants and whether a person may have inherited the condition from one or both parents. Results may also help healthcare professionals evaluate unexplained lung or liver concerns and discuss family testing when appropriate. Understanding how genetic testing works can help individuals interpret results and make informed decisions with qualified healthcare professionals.
Alpha 1 Antitrypsin Deficiency is an inherited condition associated with changes in the SERPINA1 gene. This gene provides instructions for producing alpha 1 antitrypsin, a protein primarily made in the liver. The protein helps protect lung tissue from damage caused by certain enzymes. Some genetic variants can reduce the amount of functional protein in the bloodstream or cause abnormal protein to accumulate in the liver. Genetic testing can help identify these inherited variants and provide useful information about a person's genetic status.
Genetic testing examines changes or variants in the SERPINA1 gene that are associated with Alpha 1 Antitrypsin Deficiency. It may be considered when an individual has unexplained chronic lung problems, certain liver concerns, a family history of the condition, or laboratory findings that suggest low alpha 1 antitrypsin levels. Testing methods may include blood samples, saliva samples, or other laboratory procedures depending on the healthcare provider and testing laboratory.
Common aspects of genetic testing include:
Genetic testing results are generally interpreted alongside medical history, symptoms, laboratory findings, and other clinical information. A genetic result alone may not predict exactly whether a person will develop lung or liver complications. Environmental factors, including smoking and exposure to certain airborne irritants, can also influence health outcomes. For this reason, healthcare professionals may consider several factors when discussing the meaning of a test result.
The results of genetic testing can show different combinations of SERPINA1 gene variants. Some individuals may carry one altered copy of the gene, while others may inherit altered copies from both parents. Different genetic patterns can be associated with varying levels of alpha 1 antitrypsin and different potential health implications. Healthcare professionals or genetic counselors can help explain what a particular result may mean.
Important considerations after receiving results include:
Genetic testing may provide valuable information for individuals and families affected by Alpha 1 Antitrypsin Deficiency. Understanding inherited variants can support informed conversations about personal health, family history, and possible medical evaluation. Because results can have different meanings depending on the specific genetic pattern and other health factors, professional interpretation remains an important part of the testing process.